DK0417449T3 - Arylpyrazolderivater som blodpladeaggregationsinhibitorer - Google Patents

Arylpyrazolderivater som blodpladeaggregationsinhibitorer

Info

Publication number
DK0417449T3
DK0417449T3 DK90114619.1T DK90114619T DK0417449T3 DK 0417449 T3 DK0417449 T3 DK 0417449T3 DK 90114619 T DK90114619 T DK 90114619T DK 0417449 T3 DK0417449 T3 DK 0417449T3
Authority
DK
Denmark
Prior art keywords
hydrogen
platelet aggregation
integer
aggregation inhibitors
inhibitors
Prior art date
Application number
DK90114619.1T
Other languages
English (en)
Inventor
Nicholas Andrew Meanwell
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of DK0417449T3 publication Critical patent/DK0417449T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
DK90114619.1T 1989-07-31 1990-07-30 Arylpyrazolderivater som blodpladeaggregationsinhibitorer DK0417449T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38774989A 1989-07-31 1989-07-31
US07/523,637 US4994482A (en) 1989-07-31 1990-05-10 Arylpyrazol derivatives as anti-platelet agents, compositions and use

Publications (1)

Publication Number Publication Date
DK0417449T3 true DK0417449T3 (da) 1995-04-03

Family

ID=27012007

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90114619.1T DK0417449T3 (da) 1989-07-31 1990-07-30 Arylpyrazolderivater som blodpladeaggregationsinhibitorer

Country Status (13)

Country Link
US (1) US4994482A (da)
EP (1) EP0417449B1 (da)
JP (1) JP2939909B2 (da)
AT (1) ATE118485T1 (da)
AU (1) AU630991B2 (da)
CA (1) CA2022183C (da)
DE (1) DE69016894T2 (da)
DK (1) DK0417449T3 (da)
ES (1) ES2067601T3 (da)
FI (1) FI104169B (da)
GR (1) GR3015206T3 (da)
IE (1) IE66600B1 (da)
PT (1) PT94856B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5374712A (en) * 1989-12-20 1994-12-20 Case Western Reserve University Imidazopyridinium compound and processes for isolating, identifying, and chemically synthesizing same
US5155126A (en) * 1990-03-20 1992-10-13 E. I. Du Pont De Nemours And Company Treatment of central nervous system disorders with pyrazole, pyrrole and triazole angiotensin-II receptor antagonists
DE4330959A1 (de) * 1993-09-09 1995-03-16 Schering Ag Neue Benzimidazolderivate, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
DE19649460A1 (de) * 1996-11-26 1998-05-28 Bayer Ag Neue substituierte Pyrazolderivate
DE19904391A1 (de) * 1999-02-04 2000-08-10 Bayer Ag Pyrazol-Alkylamide

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ178996A (en) * 1974-11-15 1978-06-02 Kornis G Pyrfazole amides and thioamides;herbicidal compositions
CA1098527A (en) * 1976-12-20 1981-03-31 Denis M. Bailey 1-amino-lower-alkyl-3,4-diphenyl-1h-pyrazoles
DE3228271A1 (de) * 1982-07-29 1984-02-02 A. Nattermann & Cie GmbH, 5000 Köln Triphenylimidazolyloxyalkansaeuren und ihre derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
US4826868A (en) * 1986-05-29 1989-05-02 Ortho Pharmaceutical Corporation 1,5-Diaryl-3-substituted pyrazoles pharmaceutical compositions and use
IL86926A (en) * 1987-07-13 1992-07-15 Sterling Drug Inc Diphenyl-1h-pyrazole-1-alkanamides,their preparation and antiarrhythmic compositions containing them
US4916150A (en) * 1989-03-22 1990-04-10 Sterling Drug Inc. 1H-pyrazole-1-alkanamines antiarrhythmic compositions and use
US4898880A (en) * 1989-03-22 1990-02-06 Sterling Drug Inc. N-(heterocycle)alkyl)-1H-pyrazole-1-alkanamides as antiarrhythmic agents, compositions and use

Also Published As

Publication number Publication date
US4994482A (en) 1991-02-19
AU5997090A (en) 1991-01-31
FI104169B1 (fi) 1999-11-30
PT94856A (pt) 1991-03-20
ATE118485T1 (de) 1995-03-15
JP2939909B2 (ja) 1999-08-25
PT94856B (pt) 1997-03-31
DE69016894D1 (de) 1995-03-23
IE66600B1 (en) 1996-01-24
CA2022183C (en) 2000-07-18
FI104169B (fi) 1999-11-30
IE902757A1 (en) 1991-02-27
CA2022183A1 (en) 1991-02-01
DE69016894T2 (de) 1995-06-08
AU630991B2 (en) 1992-11-12
ES2067601T3 (es) 1995-04-01
EP0417449A1 (en) 1991-03-20
FI903741A0 (fi) 1990-07-26
GR3015206T3 (en) 1995-05-31
JPH0381265A (ja) 1991-04-05
EP0417449B1 (en) 1995-02-15

Similar Documents

Publication Publication Date Title
DK0378518T3 (da) Adenosinderivater med farmaceutisk aktivitet som antihypertensiva
ES2172580T3 (es) 1,3-oxatiolanos sustituidos con propiedades antiviricas.
DE3781716D1 (de) Mittel zur ortsspezifischen alkylierung.
DE68924681D1 (de) Heterocyclische Biphosphonsäurederivate.
FI862757A0 (fi) Pyridonkarbonsyraderivat och foerfarande foer framstaellning av dessa.
FI915970A0 (fi) Laekemedel, som aer nyttiga vid vaord av cancer och som har antihistaminegenskaper.
GB8627512D0 (en) Phenoxyalkylcarboxylic acids & esters
AP9701010A0 (en) Piperidineacetic acid derivatives useful as fibrinogen.
DE3677943D1 (de) Zytoprotektive derivate zur anwendung bei ischaemischen erkrankungen, ihre herstellung und sie enthaltende zusammensetzungen.
DK0417449T3 (da) Arylpyrazolderivater som blodpladeaggregationsinhibitorer
ES8503333A1 (es) Un metodo de preparar derivados de 4-quinolona
FI890293A0 (fi) Foerfarande foer framstaellning av tioformamidderivat.
AU8672582A (en) Benzodioxane substituted imidazolines
MY102275A (en) Antimykotische aminoazole ii
DE69219219D1 (de) Verwendung von 3-Pyridazinone zur Verringerung der Blutplätchenzahl
EA200000598A1 (ru) Новые ингибиторы металлопротеазы, способ их получения и содержащие их фармацевтические композиции
ES8802507A1 (es) Procedimiento para preparar eteres 1,3-dioxano.
ATE99306T1 (de) Antagonisten von leukotrien d4.
ATE67197T1 (de) Thiadiazinon-derivate.